Healthcare Nov 18, 2020 04:51 PM (GMT+8) · EqualOcean
On November 18, Mindray medical recently received research activities and said that the current centralized purchase promoted by the state medical insurance bureau is mainly aimed at the field of drugs and high-value consumables. The products of the company's three major business lines do not involve drugs and high-value consumables. Among other products, orthopedic consumables, because of the small proportion of income, have no impact on the company's business. For example, from the perspective of potential impact in the future, medical equipment as a cost item, rather than an income item, is the natural subject of cost control and cost reduction. Therefore, medical equipment does not belong to the object of centralized purchase implemented by the National Medical Insurance Bureau.

This text is a result of machine translation.